<p>Alignment Healthcare（纳斯达克股票代码：ALHC - 获取免费报告）在周三向投资者发布的报告中，摩根大通将其目标价格从 17.00 美元上调至 18.00 美元，Benzinga 报道。该券商目前对该股票的评级为 “中性”。摩根大通的目标价格表明，相较于该股票的前一交易日收盘价，存在 5.51% 的潜在上涨空间。</p>
<p>其他一些研究分析师最近也对 ALHC 发布了报告。Weiss Ratings 在 10 月 8 日的研究报告中重申了对 Alignment Healthcare 股票的 “卖出（d-）” 评级。华尔街 Zen 在 8 月 10 日的报告中将 Alignment Healthcare 的评级从 “买入” 下调至 “持有”。高盛集团在周一的报告中重申了 “买入” 评级，并对 Alignment Healthcare 股票设定了 22.00 美元的目标价格。瑞银集团在 10 月 31 日的报告中将 Alignment Healthcare 的目标价格从 17.00 美元上调至 18.00 美元，并给予该股票 “中性” 评级。最后，巴克莱在 10 月 31 日的报告中将 Alignment Healthcare 的目标价格从 13.00 美元上调至 18.00 美元，并给予该股票 “等权重” 评级。一位分析师给予该股票 “强烈买入” 评级，七位分析师给予 “买入” 评级，四位分析师给予 “持有” 评级，一位分析师给予 “卖出” 评级。根据 MarketBeat 的数据，该股票目前的共识评级为 “适度买入”，共识目标价格为 19.85 美元。</p>
<p>获取 <strong>Alignment Healthcare</strong> 警报：</p>
<p><strong>获取我们对 ALHC 的最新股票分析</strong></p>
<h2>Alignment Healthcare 价格表现</h2>
<p>Alignment Healthcare 股票在周三的交易中下跌 0.03 美元，报 17.06 美元。该股票成交量为 1,392,839 股，而其平均成交量为 3,112,505 股。该公司的速动比率为 1.61，流动比率为 1.61，债务与股本比率为 1.99。该股票的市值为 34.1 亿美元，市盈率为-142.13，贝塔值为 1.17。该公司的 50 日移动平均线为 16.94 美元，200 日移动平均线为 15.46 美元。Alignment Healthcare 的 52 周低点为 10.18 美元，52 周高点为 21.06 美元。</p>
<p>Alignment Healthcare（纳斯达克股票代码：ALHC - 获取免费报告）最近在 10 月 30 日发布了季度财报。该公司报告每股收益（EPS）为 0.02 美元，超出市场共识预期的-0.01 美元，超出幅度为 0.03 美元。Alignment Healthcare 的股本回报率为-16.23%，净利润率为-0.57%。该季度的营业收入为 9.937 亿美金，而分析师预期为 9.809 亿美金。去年同期，该公司每股收益为-0.14 美元。Alignment Healthcare 本季度的收入较去年同期增长了 43.5%。Alignment Healthcare 已设定 2025 财年的每股收益指导。2025 年第四季度的指导为每股收益。研究分析师预计 Alignment Healthcare 在当前财年将发布-0.69 美元的每股收益。</p>
<h2>内部买卖</h2>
<p>在其他 Alignment Healthcare 的新闻中，内部人士 Hyong Kim 在 10 月 9 日的交易中出售了 51,379 股该股票。该股票的平均售价为 17.57 美元，总交易额为 902,729.03 美元。出售后，该内部人士直接持有该公司 362,333 股股票，估值约为 6,366,190.81 美元。此交易代表其持股比例减少了 12.42%。该出售在向证券交易委员会提交的文件中披露，相关文件可通过此链接访问。此外，董事 Atlantic（Aln Hlth）L. General 在 9 月 17 日的交易中出售了 6,246,096 股该公司的股票。该股票的平均售价为 16.01 美元，总价值为 99,999,996.96 美元。出售后，该董事在公司持有 24,596,079 股股票，估值为 393,783,224.79 美元。此交易代表其持股比例减少了 20.25%。有关此出售的更多细节可在官方 SEC 披露中找到。在过去 90 天内，内部人士已出售公司股票 7,427,716 股，价值 119,650,069 美元。内部人士持有该股票的比例为 6.60%。</p>
<h2>Alignment Healthcare 的机构交易</h2>
<p>几家机构投资者最近对该公司的持股进行了调整。Principal Financial Group Inc.在第三季度将其在 Alignment Healthcare 的股份增加了 40.1%。Principal Financial Group Inc.目前持有 167,376 股该公司的股票，价值 2,921,000 美元，此前在上一季度增持了 47,895 股。亚利桑那州退休系统在第三季度将其在 Alignment Healthcare 的股份增加了 33.1%。亚利桑那州退休系统目前持有 40,967 股该公司的股票，价值 715,000 美元，此前在上一季度增持了 10,195 股。纽约州共同退休基金在第三季度将其在 Alignment Healthcare 的股份增加了 3.1%。纽约州共同退休基金目前持有 207,461 股该公司的股票，价值 3,620,000 美元，此前在上一季度增持了 6,200 股。先锋个性化指数管理公司在第三季度获得了 Alignment Healthcare 的新头寸，价值 242,000 美元。最后，Y Intercept Hong Kong Ltd 在第三季度获得了 Alignment Healthcare 的新头寸，价值 3,499,000 美元。对冲基金和其他机构投资者持有该公司 86.19% 的股票。</p>
<h2>Alignment Healthcare 公司简介</h2>
<p>（获取免费报告）</p>
<p>Alignment Healthcare, Inc.是一家技术驱动的医疗保险优势公司，为美国老年人提供以消费者为中心的医疗保健平台。它通过医疗保险优势计划提供定制的医疗保健，以满足多样化老年人的需求。该公司成立于 2013 年，总部位于加利福尼亚州橙县。</p>
<h2>推荐故事</h2>
<ul>
<li>我们更看好的五只股票，而非 Alignment Healthcare</li>
<li>动荡市场中的资产配置策略</li>
<li>Spotify 发布巨大的每股收益超预期：股价仍然大幅低于高点</li>
<li>现在购买的三只最佳蓝筹股</li>
<li>Stardust 的战略锂交易可能成为游戏规则的改变者</li>
<li>如何计算股票利润</li>
<li>价格震惊：为什么金佰利的抛售反应过度</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxIQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxIQw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 $1,000 在 Alignment Healthcare 吗？</h2>
<p>在考虑 Alignment Healthcare 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Alignment Healthcare 并不在名单上。</p>
<p>虽然 Alignment Healthcare 目前在分析师中有中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

ALHC

<p>摩根大通已将 Alignment Healthcare（纳斯达克代码：ALHC）的目标价格从 17.00 美元上调至 18.00 美元，维持 “中性” 评级。这表明相较于前一交易日收盘价有 5.51% 的潜在上涨空间。其他分析师的评级各不相同，Weiss Ratings 给出 “卖出” 评级，而高盛则给予 “买入” 评级，目标价为 22.00 美元。该股票交易价格为 17.06 美元，市值为 34.1 亿美元。近期的内部销售和机构投资反映出市场对该公司的持续关注，该公司报告的年收入增长率为 43.5%</p>

<p>Alignment Healthcare (NASDAQ:ALHC - Get Free Report) had its price objective upped by JPMorgan Chase &amp; Co. from $17.00 to $18.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a &#34;neutral&#34; rating on the stock. JPMorgan Chase &amp; Co.'s price target indicates a potential upside of 5.51% from the stock's previous close.</p>
<div class="lb-trans"><p>Alignment Healthcare（纳斯达克股票代码：ALHC - 获取免费报告）在周三向投资者发布的报告中，摩根大通将其目标价格从 17.00 美元上调至 18.00 美元，Benzinga 报道。该券商目前对该股票的评级为 “中性”。摩根大通的目标价格表明，相较于该股票的前一交易日收盘价，存在 5.51% 的潜在上涨空间。</p>
</div><p>A number of other research analysts have also recently issued reports on ALHC. Weiss Ratings reiterated a &#34;sell (d-)&#34; rating on shares of Alignment Healthcare in a research note on Wednesday, October 8th. Wall Street Zen lowered Alignment Healthcare from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a report on Sunday, August 10th. The Goldman Sachs Group reissued a &#34;buy&#34; rating and issued a $22.00 target price on shares of Alignment Healthcare in a report on Monday. UBS Group lifted their target price on Alignment Healthcare from $17.00 to $18.00 and gave the stock a &#34;neutral&#34; rating in a report on Friday, October 31st. Finally, Barclays lifted their target price on Alignment Healthcare from $13.00 to $18.00 and gave the stock an &#34;equal weight&#34; rating in a report on Friday, October 31st. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $19.85.</p>
<div class="lb-trans"><p>其他一些研究分析师最近也对 ALHC 发布了报告。Weiss Ratings 在 10 月 8 日的研究报告中重申了对 Alignment Healthcare 股票的 “卖出（d-）” 评级。华尔街 Zen 在 8 月 10 日的报告中将 Alignment Healthcare 的评级从 “买入” 下调至 “持有”。高盛集团在周一的报告中重申了 “买入” 评级，并对 Alignment Healthcare 股票设定了 22.00 美元的目标价格。瑞银集团在 10 月 31 日的报告中将 Alignment Healthcare 的目标价格从 17.00 美元上调至 18.00 美元，并给予该股票 “中性” 评级。最后，巴克莱在 10 月 31 日的报告中将 Alignment Healthcare 的目标价格从 13.00 美元上调至 18.00 美元，并给予该股票 “等权重” 评级。一位分析师给予该股票 “强烈买入” 评级，七位分析师给予 “买入” 评级，四位分析师给予 “持有” 评级，一位分析师给予 “卖出” 评级。根据 MarketBeat 的数据，该股票目前的共识评级为 “适度买入”，共识目标价格为 19.85 美元。</p>
</div><p>Get <strong>Alignment Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Alignment Healthcare</strong> 警报：</p>
</div><p><strong>Get Our Latest Stock Analysis on ALHC</strong></p>
<div class="lb-trans"><p><strong>获取我们对 ALHC 的最新股票分析</strong></p>
</div><h2>Alignment Healthcare Price Performance</h2>
<div class="lb-trans"><h2>Alignment Healthcare 价格表现</h2>
</div><p>Shares of Alignment Healthcare stock traded down $0.03 during trading on Wednesday, hitting $17.06. 1,392,839 shares of the stock traded hands, compared to its average volume of 3,112,505. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 1.99. The stock has a market cap of $3.41 billion, a price-to-earnings ratio of -142.13 and a beta of 1.17. The firm's fifty day moving average is $16.94 and its 200-day moving average is $15.46. Alignment Healthcare has a 52 week low of $10.18 and a 52 week high of $21.06.</p>
<div class="lb-trans"><p>Alignment Healthcare 股票在周三的交易中下跌 0.03 美元，报 17.06 美元。该股票成交量为 1,392,839 股，而其平均成交量为 3,112,505 股。该公司的速动比率为 1.61，流动比率为 1.61，债务与股本比率为 1.99。该股票的市值为 34.1 亿美元，市盈率为-142.13，贝塔值为 1.17。该公司的 50 日移动平均线为 16.94 美元，200 日移动平均线为 15.46 美元。Alignment Healthcare 的 52 周低点为 10.18 美元，52 周高点为 21.06 美元。</p>
</div><p>Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last posted its quarterly earnings results on Thursday, October 30th. The company reported $0.02 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.01) by $0.03. Alignment Healthcare had a negative return on equity of 16.23% and a negative net margin of 0.57%.The business had revenue of $993.70 million for the quarter, compared to analyst estimates of $980.90 million. During the same period last year, the company earned ($0.14) EPS. Alignment Healthcare's revenue for the quarter was up 43.5% compared to the same quarter last year. Alignment Healthcare has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS. Research analysts expect that Alignment Healthcare will post -0.69 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Alignment Healthcare（纳斯达克股票代码：ALHC - 获取免费报告）最近在 10 月 30 日发布了季度财报。该公司报告每股收益（EPS）为 0.02 美元，超出市场共识预期的-0.01 美元，超出幅度为 0.03 美元。Alignment Healthcare 的股本回报率为-16.23%，净利润率为-0.57%。该季度的营业收入为 9.937 亿美金，而分析师预期为 9.809 亿美金。去年同期，该公司每股收益为-0.14 美元。Alignment Healthcare 本季度的收入较去年同期增长了 43.5%。Alignment Healthcare 已设定 2025 财年的每股收益指导。2025 年第四季度的指导为每股收益。研究分析师预计 Alignment Healthcare 在当前财年将发布-0.69 美元的每股收益。</p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>内部买卖</h2>
</div><p>In other Alignment Healthcare news, insider Hyong Kim sold 51,379 shares of the stock in a transaction dated Thursday, October 9th. The stock was sold at an average price of $17.57, for a total transaction of $902,729.03. Following the sale, the insider directly owned 362,333 shares of the company's stock, valued at approximately $6,366,190.81. This trade represents a 12.42% decrease in their position. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which is accessible through this link. Also, Director Atlantic (Aln Hlth) L. General sold 6,246,096 shares of the firm's stock in a transaction dated Wednesday, September 17th. The shares were sold at an average price of $16.01, for a total value of $99,999,996.96. Following the sale, the director owned 24,596,079 shares in the company, valued at $393,783,224.79. This trade represents a 20.25% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 7,427,716 shares of company stock valued at $119,650,069 over the last 90 days. 6.60% of the stock is owned by insiders.</p>
<div class="lb-trans"><p>在其他 Alignment Healthcare 的新闻中，内部人士 Hyong Kim 在 10 月 9 日的交易中出售了 51,379 股该股票。该股票的平均售价为 17.57 美元，总交易额为 902,729.03 美元。出售后，该内部人士直接持有该公司 362,333 股股票，估值约为 6,366,190.81 美元。此交易代表其持股比例减少了 12.42%。该出售在向证券交易委员会提交的文件中披露，相关文件可通过此链接访问。此外，董事 Atlantic（Aln Hlth）L. General 在 9 月 17 日的交易中出售了 6,246,096 股该公司的股票。该股票的平均售价为 16.01 美元，总价值为 99,999,996.96 美元。出售后，该董事在公司持有 24,596,079 股股票，估值为 393,783,224.79 美元。此交易代表其持股比例减少了 20.25%。有关此出售的更多细节可在官方 SEC 披露中找到。在过去 90 天内，内部人士已出售公司股票 7,427,716 股，价值 119,650,069 美元。内部人士持有该股票的比例为 6.60%。</p>
</div><h2>Institutional Trading of Alignment Healthcare</h2>
<div class="lb-trans"><h2>Alignment Healthcare 的机构交易</h2>
</div><p>Several institutional investors have recently made changes to their positions in the company. Principal Financial Group Inc. grew its stake in shares of Alignment Healthcare by 40.1% in the third quarter. Principal Financial Group Inc. now owns 167,376 shares of the company's stock worth $2,921,000 after acquiring an additional 47,895 shares in the last quarter. Arizona State Retirement System grew its stake in shares of Alignment Healthcare by 33.1% in the third quarter. Arizona State Retirement System now owns 40,967 shares of the company's stock worth $715,000 after acquiring an additional 10,195 shares in the last quarter. New York State Common Retirement Fund grew its stake in shares of Alignment Healthcare by 3.1% in the third quarter. New York State Common Retirement Fund now owns 207,461 shares of the company's stock worth $3,620,000 after acquiring an additional 6,200 shares in the last quarter. Vanguard Personalized Indexing Management LLC acquired a new position in shares of Alignment Healthcare in the third quarter worth $242,000. Finally, Y Intercept Hong Kong Ltd acquired a new position in shares of Alignment Healthcare in the third quarter worth $3,499,000. Hedge funds and other institutional investors own 86.19% of the company's stock.</p>
<div class="lb-trans"><p>几家机构投资者最近对该公司的持股进行了调整。Principal Financial Group Inc.在第三季度将其在 Alignment Healthcare 的股份增加了 40.1%。Principal Financial Group Inc.目前持有 167,376 股该公司的股票，价值 2,921,000 美元，此前在上一季度增持了 47,895 股。亚利桑那州退休系统在第三季度将其在 Alignment Healthcare 的股份增加了 33.1%。亚利桑那州退休系统目前持有 40,967 股该公司的股票，价值 715,000 美元，此前在上一季度增持了 10,195 股。纽约州共同退休基金在第三季度将其在 Alignment Healthcare 的股份增加了 3.1%。纽约州共同退休基金目前持有 207,461 股该公司的股票，价值 3,620,000 美元，此前在上一季度增持了 6,200 股。先锋个性化指数管理公司在第三季度获得了 Alignment Healthcare 的新头寸，价值 242,000 美元。最后，Y Intercept Hong Kong Ltd 在第三季度获得了 Alignment Healthcare 的新头寸，价值 3,499,000 美元。对冲基金和其他机构投资者持有该公司 86.19% 的股票。</p>
</div><h2>Alignment Healthcare Company Profile</h2>
<div class="lb-trans"><h2>Alignment Healthcare 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.</p>
<div class="lb-trans"><p>Alignment Healthcare, Inc.是一家技术驱动的医疗保险优势公司，为美国老年人提供以消费者为中心的医疗保健平台。它通过医疗保险优势计划提供定制的医疗保健，以满足多样化老年人的需求。该公司成立于 2013 年，总部位于加利福尼亚州橙县。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than Alignment Healthcare</li>
<li>Asset Allocation Strategies in Volatile Markets</li>
<li>Spotify Posts Huge EPS Beat: Shares Are Still Down Big From Highs</li>
<li>The 3 Best Blue-Chip Stocks to Buy Now</li>
<li>Stardust's Strategic Lithium Deal Could Be a Game-Changer</li>
<li>How to Calculate Stock Profit</li>
<li>Sticker Shock: Why Kimberly-Clark's Sell-Off Is an Overreaction</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，而非 Alignment Healthcare</li>
<li>动荡市场中的资产配置策略</li>
<li>Spotify 发布巨大的每股收益超预期：股价仍然大幅低于高点</li>
<li>现在购买的三只最佳蓝筹股</li>
<li>Stardust 的战略锂交易可能成为游戏规则的改变者</li>
<li>如何计算股票利润</li>
<li>价格震惊：为什么金佰利的抛售反应过度</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxIQw" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&amp;Symbol=ALHC"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Alignment Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 $1,000 在 Alignment Healthcare 吗？</h2>
</div><p>Before you consider Alignment Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Alignment Healthcare 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alignment Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Alignment Healthcare 并不在名单上。</p>
</div><p>While Alignment Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Alignment Healthcare 目前在分析师中有中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

摩根大通对 Alignment Healthcare（纳斯达克股票代码：ALHC）的股价发布了乐观的预测